Raymond James Financial’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
DSCM
SFM
AC
SBH
BAM
Raymond James Financial's ANGO Position: Q3 2025 in Review
Raymond James Financial sold out of AngioDynamics (ANGO) in Q3 2025, closing a stake of 9,033 shares — an estimated $89.6K sold.
Raymond James Financial first reported a position in ANGO in Q2 2025 and held it in 1 quarter. The position peaked at $89.6K in Q2 2025. 144 funds tracked by Wall St. Rank hold ANGO as of Q3 2025.
- Raymond James Financial reported no remaining AngioDynamics position as of Q3 2025 after selling out during the quarter.
- Raymond James Financial sold 9,033 AngioDynamics shares in Q3 2025, an estimated $89.6K.
- Raymond James Financial first reported a position in AngioDynamics in Q2 2025 and held it in 1 quarter.
- Raymond James Financial's AngioDynamics position peaked at $89.6K in Q2 2025.
- 144 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2025.
Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.